STAT on Stateside Daily

STAT+: Immunovant shares surge on arthritis trial data

STAT1h ago

STAT+: Acting head of NIH’s infectious disease institute reported to have stepped down

STAT3h ago

STAT+: Elevance executive ordered to testify in Medicare Advantage fraud case

STAT3h ago

Senate committee questions NIH director on 2027 budget

STAT3h ago

STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more

STAT4h ago

How Florida hospitals won big in Medicaid funds (just in time)

STAT5h ago

STAT+: Lilly’s ‘triple-G’ drug leads to bariatric-surgery levels of weight loss in trial

STAT7h ago

Opinion: Living with bullet fragments in the body can have long-term medical consequences

STAT9h ago

STAT+: Are ‘AI co-scientist’ tools actually useful for scientists?

STAT9h ago

STAT+: After warning letter, Whoop and FDA in discussions about controversial blood pressure feature

STAT9h ago

Opinion: STAT+: Dark times ahead at the FDA

STAT9h ago

Congressional Democrats try to force a vote to end Medicare AI prior authorization pilot

STAT22h ago

STAT+: Pioneering trial for treating genetic disease before birth nears reality

STAT23h ago

Surgeon general’s office issues warning on screen time for children

STAT23h ago

STAT+: Florida hospitals win $8 billion in extra Medicaid funds

STAT23h ago

STAT+: Scientists track cellular disruptions that lead to type 1 diabetes

STAT23h ago

Opinion: I saw Ebola as both doctor and patient. I wish people cared more about the Africans I worked alongside

STAT1d ago

STAT+: Biotech execs, academic expert lament impact of FDA turnover on rare disease drug development

STAT1d ago

STAT+: Kennedy fires two leaders on preventive services task force

STAT1d ago

STAT+: Drugmakers guard IP more tightly amid China competition

STAT1d ago

STAT+: Kennedy names interim surgeon general amid vacancies atop health department

STAT1d ago

STAT+: Pharmalittle: We’re reading about biotech investors’ mood, a former FDA head’s confidence, and more

STAT1d ago

There’s a leadership vacuum at NIH, too

STAT1d ago

After a critique from Rubio, WHO defends work on Ebola response

STAT1d ago

STAT+: Senate Democrats propose adding long-term care benefit to Medicare

STAT1d ago

STAT+: OpenEvidence makes its pitch to hospitals. ‘We’re not crazy monsters’

STAT1d ago

STAT+: NIH behind in filling top roles, with 15 of 27 institutes led by acting directors

STAT1d ago

Opinion: The rise of perimenopause misinformation

STAT1d ago

STAT+: 23andMe offers to connect users’ DNA data with medical records

STAT1d ago

STAT

STAT+: RFK Jr.’s screen time warning

STAT+: RFK Jr.’s screen time warning

Latest from STAT

STAT+: Immunovant shares surge on arthritis trial data

STAT+: Acting head of NIH’s infectious disease institute reported to have stepped down

STAT+: Elevance executive ordered to testify in Medicare Advantage fraud case

Senate committee questions NIH director on 2027 budget

STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more

How Florida hospitals won big in Medicaid funds (just in time)

STAT+: Lilly’s ‘triple-G’ drug leads to bariatric-surgery levels of weight loss in trial

Opinion: Living with bullet fragments in the body can have long-term medical consequences

STAT+: Are ‘AI co-scientist’ tools actually useful for scientists?

STAT+: After warning letter, Whoop and FDA in discussions about controversial blood pressure feature

Opinion: STAT+: Dark times ahead at the FDA

Congressional Democrats try to force a vote to end Medicare AI prior authorization pilot

STAT+: Pioneering trial for treating genetic disease before birth nears reality

Surgeon general’s office issues warning on screen time for children

STAT+: Florida hospitals win $8 billion in extra Medicaid funds

STAT+: Scientists track cellular disruptions that lead to type 1 diabetes

Opinion: I saw Ebola as both doctor and patient. I wish people cared more about the Africans I worked alongside

STAT+: Biotech execs, academic expert lament impact of FDA turnover on rare disease drug development

STAT+: Kennedy fires two leaders on preventive services task force

STAT+: Drugmakers guard IP more tightly amid China competition

STAT+: Kennedy names interim surgeon general amid vacancies atop health department

STAT+: Pharmalittle: We’re reading about biotech investors’ mood, a former FDA head’s confidence, and more

There’s a leadership vacuum at NIH, too

After a critique from Rubio, WHO defends work on Ebola response

STAT+: Senate Democrats propose adding long-term care benefit to Medicare

STAT+: OpenEvidence makes its pitch to hospitals. ‘We’re not crazy monsters’

STAT+: NIH behind in filling top roles, with 15 of 27 institutes led by acting directors

Opinion: The rise of perimenopause misinformation

STAT+: 23andMe offers to connect users’ DNA data with medical records

Browse more

Reader

Trust & legal

Across the network

STAT

STAT+: RFK Jr.’s screen time warning

STAT+: RFK Jr.’s screen time warning

Latest from STAT

STAT+: Immunovant shares surge on arthritis trial data

STAT+: Acting head of NIH’s infectious disease institute reported to have stepped down

STAT+: Elevance executive ordered to testify in Medicare Advantage fraud case

Senate committee questions NIH director on 2027 budget

STAT+: Pharmalittle: We&#8217;re reading about a Lilly obesity drug trial, statistics for an Alzheimer&#8217;s drug, and more

How Florida hospitals won big in Medicaid funds (just in time)

STAT+: Lilly’s ‘triple-G’ drug leads to bariatric-surgery levels of weight loss in trial

Opinion: Living with bullet fragments in the body can have long-term medical consequences

STAT+: Are &#8216;AI co-scientist&#8217; tools actually useful for scientists?

STAT+: After warning letter, Whoop and FDA in discussions about controversial blood pressure feature

Opinion: STAT+: Dark times ahead at the FDA

Congressional Democrats try to force a vote to end Medicare AI prior authorization pilot

STAT+: Pioneering trial for treating genetic disease before birth nears reality

Surgeon general’s office issues warning on screen time for children

STAT+: Florida hospitals win $8 billion in extra Medicaid funds

STAT+: Scientists track cellular disruptions that lead to type 1 diabetes

Opinion: I saw Ebola as both doctor and patient. I wish people cared more about the Africans I worked alongside

STAT+: Biotech execs, academic expert lament impact of FDA turnover on rare disease drug development

STAT+: Kennedy fires two leaders on preventive services task force

STAT+: Drugmakers guard IP more tightly amid China competition

STAT+: Kennedy names interim surgeon general amid vacancies atop health department

STAT+: Pharmalittle: We’re reading about biotech investors&#8217; mood, a former FDA head&#8217;s confidence, and more

There&#8217;s a leadership vacuum at NIH, too

After a critique from Rubio, WHO defends work on Ebola response

STAT+: Senate Democrats propose adding long-term care benefit to Medicare

STAT+: OpenEvidence makes its pitch to hospitals. &#8216;We’re not crazy monsters’

STAT+: NIH behind in filling top roles, with 15 of 27 institutes led by acting directors

Opinion: The rise of perimenopause misinformation

STAT+: 23andMe offers to connect users’ DNA data with medical records

Browse more

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about a Lilly obesity drug trial, statistics for an Alzheimer’s drug, and more

STAT+: Are ‘AI co-scientist’ tools actually useful for scientists?

STAT+: Pharmalittle: We’re reading about biotech investors’ mood, a former FDA head’s confidence, and more

There’s a leadership vacuum at NIH, too

STAT+: OpenEvidence makes its pitch to hospitals. ‘We’re not crazy monsters’